US2008260810A1PendingUtilityA1

Hemostat

Assignee: ZHANG GUANGHUIPriority: Oct 20, 2004Filed: Oct 17, 2005Published: Oct 23, 2008
Est. expiryOct 20, 2024(expired)· nominal 20-yr term from priority
B32B 23/10A61L 15/64A61L 15/28B32B 27/36Y10T442/2525A61L 15/44B32B 2262/062A61L 2300/608B32B 2250/20B32B 2556/00B32B 5/26B32B 5/024B32B 2307/726B32B 2262/0276B32B 23/02B32B 5/022B32B 5/026A61L 2400/04B32B 2262/06A61L 15/26A61L 15/32B32B 2262/04A61L 2300/418A61L 15/42A61F 13/01029
53
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention is directed towards a hemostat comprising an absorbable foam, an absorbable woven or knitted fabric, thrombin and/or fibrinogen.

Claims

exact text as granted — not AI-modified
1 . A hemostat comprising an absorbable foam, an absorbable woven or knitted fabric, thrombin and fibrinogen. 
     
     
         2 . The hemostat of  claim 1 , where the foam comprises one or more polymers selected from the group consisting of polysaccharides, albumin, chitin, carboxymethyl chitin, hyaluronic acid, salts of hyaluronic acid, alginate, alginic acid, propylene glycol alginate, glycogen, dextran, dextran sulfate, curdlan, pectin, pullulan, xanthan, chondroitin, chondroitin sulfates, carboxymethyl dextran, carboxymethyl chitosan, chitosan, heparin, heparin sulfate, heparan, heparan sulfate, dermatan sulfate, keratan sulfate, carrageenans, chitosan, starch, amylose, amylopectin, poly-N-glucosamine, polymannuronic acid, polyglucuronic acid polyguluronic acid, and derivatives of any of the above. 
     
     
         3 . The hemostat of  claim 2 , where the foam comprises a polysaccharide selected from the group consisting of methylcellulose, alkylhydroxyalkyl cellulose, hydroxyalkyl cellulose, cellulose sulfate, salts of carboxymethyl cellulose, carboxymethyl cellulose, carboxyethyl cellulose. 
     
     
         4 . The hemostat of  claim 3 , where the absorbable woven or knitted fabric comprises oxidized polysaccharides. 
     
     
         5 . The hemostat of  claim 4 , where the absorbable woven or knitted fabric comprises oxidized cellulose. 
     
     
         6 . The hemostat of  claim 5 , where the absorbable woven or knitted fabric comprises oxidized regenerated cellulose. 
     
     
         7 . The hemostat of  claim 5 , where the absorbable woven or knitted fabric is an absorbable knitted fabric comprising oxidized regenerated cellulose. 
     
     
         8 . The hemostat of  claim 1 , where the foam comprises carboxymethyl cellulose and albumin, the absorbable woven or knitted fabric comprises oxidized regenerated cellulose, and the thrombin and fibrinogen are incorporated into or sprayed onto the foam. 
     
     
         9 . The hemostat of  claim 8 , where the weight ratio of carboxymethyl cellulose to the albumin ranges from about 1:8 to 8:1 by weight. 
     
     
         10 . The hemostat of  claim 8 , wherein the thrombin activity on the hemostat ranges from about 20 to 500 IU/cm 2 , and the fibrinogen activity ranges from about 2 to 15 mg/cm 2 .

Join the waitlist — get patent alerts

Track US2008260810A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.